Monographs: Pharmaceutical substances: Erythromycin ethylsuccinate (Erythromycini ethylsuccinas)Erythromycin ethylsuccinate for parenteral use Molecular formula. C43H75NO16 Relative molecular mass. 862.1 Graphic formula.
Chemical name. Erythromycin 2'-(ethylsuccinate); erythromycin 2'(ethyl butanedioate); [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione 2'-(ethyl butanedioate); CAS Reg. No. 1264-62-6. Description. A white or slightly yellow, crystalline powder; odourless or almost odourless. Solubility. Very slightly soluble in water; soluble in ethanol (~750 g/l) TS and macrogol 400 R. Labelling. The designation Erythromycin ethylsuccinate for parenteral use indicates that the substance complies with the additional requirement for Erythromycin ethylsuccinate and may be used for parenteral administration. Category. Antibacterial drug. Storage. Erythromycin ethylsuccinate should be kept in a tightly closed container, protected from light. Requirements Definition. Erythromycin ethylsuccinate contains not less than 740 International Units of erythromycin per mg, calculated with reference to the anhydrous substance. Identity tests • Either test A alone or tests B, C and D may be applied.
Sulfated ash. Not more than 10 mg/g. Water. Determine as described under 2.8 Determination of water by the Karl Fischer method, Method A, using about 0.5 g of the substance; the water content is not more than 30 mg/g. pH value. Shake 0.5 g with 50 mL of carbon-dioxide-free water R; pH of the suspension, 6.0-8.5. Assay. Dissolve 50 mg in sufficient methanol R to produce 100 mL and carry out the assay as described under 3.1 Microbiological assay of antibiotics, using Bacillus pumilus (NCTC 8241 or ATCC 14884) as the test organism, culture medium Cm1 with a final pH of 8.0-8.1, sterile phosphate buffer, pH 8.0 TS1 or TS2, an appropriate concentration of erythromycin (usually between 5 and 25 IU per mL), and an incubation temperature of 35-39 °C. The precision of the assay is such that the fiducial limits of error of the estimated potency (P = 0.95) are not less than 95% and not more than 105% of the estimated potency. The upper fiducial limit of error of the estimated potency (P = 0.95) is not less than 740 IU of erythromycin per mg, calculated with reference to the anhydrous substance. Additional Requirement for Erythromycin Ethylsuccinate for Parenteral Use Complies with the monograph for "Parenteral preparations". |